Can-Fite BioPharma Files 6-K, Incorporates Press Release
Ticker: CANF · Form: 6-K · Filed: Oct 18, 2024 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, sec-filing
Related Tickers: CFBI
TL;DR
CFBI filed a 6-K, incorporating press release into S-8/F-3 filings. No major news, just procedural.
AI Summary
On October 18, 2024, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating by reference the first and third paragraphs of a press release (Exhibit 99.1) into its existing Registration Statements on Form S-8 and Form F-3. This filing relates to the month of October 2024 and is being made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing updates SEC registration statements, potentially impacting how investors view the company's ongoing disclosures and its ability to issue securities.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not appear to contain new material financial or operational information.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Registrant
- October 18, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form S-8 (document) — Incorporated Registration Statement
- Form F-3 (document) — Incorporated Registration Statement
FAQ
What is the purpose of this Form 6-K filing by Can-Fite BioPharma Ltd.?
The purpose is to report information under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, specifically incorporating by reference the first and third paragraphs of a press release into its existing Registration Statements.
Which Registration Statements are being updated by this filing?
The filing incorporates information into Can-Fite BioPharma Ltd.'s Registration Statements on Form S-8 (File Nos. 333-227753, 333-271384, and 333-278525) and Form F-3 (File Nos. 333-236064, 333-274316, 333-262055, 333-276000, and 333-281872).
What is the filing date for this Form 6-K?
The filing date is October 18, 2024.
Is Can-Fite BioPharma Ltd. required to file annual reports under Form 20-F or Form 40-F?
Yes, Can-Fite BioPharma Ltd. indicates it files annual reports under Form 20-F.
What specific exhibit is being incorporated by reference into the registration statements?
The first and third paragraphs of the press release attached as Exhibit 99.1 are incorporated by reference.
Filing Stats: 267 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-10-18 09:23:54
Filing Documents
- ea0217992-6k_canfite.htm (6-K) — 11KB
- ea021799201ex99-1_canfite.htm (EX-99.1) — 15KB
- 0001213900-24-088719.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 18, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 2